Repository logo
 
Publication

Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure

dc.contributor.authorGjini, Erida
dc.contributor.authorGomes, M. Gabriela M.
dc.date.accessioned2016-03-21T13:34:54Z
dc.date.available2016-03-21T13:34:54Z
dc.date.issued2016-03
dc.description.abstractThe efficacy of vaccines is typically estimated prior to implementation, on the basis of randomized controlled trials. This does not preclude, however, subsequent assessment post-licensure, while mass-immunization and nonlinear transmission feedbacks are in place. In this paper we show how cross-sectional prevalence data post-vaccination can be interpreted in terms of pathogen transmission processes and vaccine parameters, using a dynamic epidemiological model. We advocate the use of such frameworks for model-based vaccine evaluation in the field, fitting trajectories of cross-sectional prevalence of pathogen strains before and after intervention. Using SI and SIS models, we illustrate how prevalence ratios in vaccinated and non-vaccinated hosts depend on true vaccine efficacy, the absolute and relative strength of competition between target and non-target strains, the time post follow-up, and transmission intensity. We argue that a mechanistic approach should be added to vaccine efficacy estimation against multi-type pathogens, because it naturally accounts for inter-strain competition and indirect effects, leading to a robust measure of individual protection per contact. Our study calls for systematic attention to epidemiological feedbacks when interpreting population level impact. At a broader level, our parameter estimation procedure provides a promising proof of principle for a generalizable framework to infer vaccine efficacy post-licensure.pt_PT
dc.description.sponsorshipsem patrocinadores explícitos no artigo.pt_PT
dc.identifier.citationErida Gjini, M. Gabriela M. Gomes, Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure, Epidemics, Volume 14, March 2016, Pages 71-82, ISSN 1755-4365, http://dx.doi.org/10.1016/j.epidem.2015.11.001.pt_PT
dc.identifier.doi10.1016/j.epidem.2015.11.001pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.7/565
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsivier Science BVpt_PT
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S1755436515000948pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectVaccination modelpt_PT
dc.subjectStrain replacementpt_PT
dc.subjectCo-infectionpt_PT
dc.subjectCompetitionpt_PT
dc.subjectODE parameter inferencept_PT
dc.titleExpanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensurept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage82pt_PT
oaire.citation.startPage71pt_PT
oaire.citation.titleEpidemicspt_PT
oaire.citation.volume14pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
1-s2.0-S1755436515000948-main.pdf
Size:
1.3 MB
Format:
Adobe Portable Document Format
Description:
artigo principal
Loading...
Thumbnail Image
Name:
mmc1.pdf
Size:
900.02 KB
Format:
Adobe Portable Document Format
Description:
material suplementar 1
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections